Handelsbanken Fonder AB Increases Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Handelsbanken Fonder AB raised its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 29.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 658,929 shares of the real estate investment trust’s stock after buying an additional 148,755 shares during the quarter. Handelsbanken Fonder AB owned about 0.09% of Healthpeak Properties worth $13,356,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the business. HM Payson & Co. bought a new stake in shares of Healthpeak Properties in the third quarter worth $25,000. S.A. Mason LLC bought a new stake in Healthpeak Properties during the third quarter valued at about $26,000. Fortitude Family Office LLC bought a new stake in Healthpeak Properties during the third quarter valued at about $32,000. Barrett & Company Inc. bought a new stake in Healthpeak Properties during the third quarter valued at about $33,000. Finally, Avior Wealth Management LLC bought a new stake in Healthpeak Properties during the third quarter valued at about $37,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on DOC shares. Robert W. Baird cut their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Tuesday, February 11th. Mizuho cut their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Wells Fargo & Company cut their price target on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a report on Tuesday, December 10th. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective for the company in a research note on Wednesday, January 15th. Finally, Wedbush dropped their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, February 14th. One research analyst has rated the stock with a sell rating, three have given a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $24.00.

Healthpeak Properties Stock Down 0.1 %

DOC stock opened at $19.75 on Friday. The firm has a market cap of $13.81 billion, a PE ratio of 56.42, a PEG ratio of 2.14 and a beta of 1.15. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. Healthpeak Properties, Inc. has a one year low of $16.01 and a one year high of $23.26. The firm’s 50 day moving average price is $20.20 and its 200-day moving average price is $21.39.

Healthpeak Properties Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th will be given a $0.305 dividend. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.22 dividend on an annualized basis and a yield of 6.18%. Healthpeak Properties’s payout ratio is presently 348.58%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.